Literature DB >> 22467296

Novel animal models of pediatric epilepsy.

Stéphane Auvin1, Eduardo Pineda, Don Shin, Pierre Gressens, Andrey Mazarati.   

Abstract

When mimicking epileptic processes in a laboratory setting, it is important to understand the differences between experimental models of seizures and epilepsy. Because human epilepsy is defined by the appearance of multiple spontaneous recurrent seizures, the induction of a single acute seizure without recurrence does not constitute an adequate epilepsy model. Animal models of epilepsy might be useful for various tasks. They allow for the investigation of pathophysiological mechanisms of the disease, the evaluation, or the development of new antiepileptic treatments, and the study of the consequences of recurrent seizures and neurological and psychiatric comorbidities. Although clinical relevance is always an issue, the development of models of pediatric epilepsies is particularly challenging due to the existence of several key differences in the dynamics of human and rodent brain maturation. Another important consideration in modeling pediatric epilepsy is that "children are not little adults," and therefore a mere application of models of adult epilepsies to the immature specimens is irrelevant. Herein, we review the models of pediatric epilepsy. First, we illustrate the differences between models of pediatric epilepsy and models of the adulthood consequences of a precipitating insult in early life. Next, we focus on new animal models of specific forms of epilepsies that occur in the developing brain. We conclude by emphasizing the deficiencies in the existing animal models and the need for several new models.

Entities:  

Mesh:

Year:  2012        PMID: 22467296      PMCID: PMC3337021          DOI: 10.1007/s13311-012-0119-8

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  148 in total

Review 1.  Absence epilepsy: advances in experimental animal models.

Authors:  O C Snead; A Depaulis; M Vergnes; C Marescaux
Journal:  Adv Neurol       Date:  1999

2.  Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study.

Authors:  Rima Nabbout; Cristiana Copioli; Mathilde Chipaux; Nicole Chemaly; Isabelle Desguerre; Olivier Dulac; Catherine Chiron
Journal:  Epilepsia       Date:  2011-05-13       Impact factor: 5.864

3.  How well can epilepsy syndromes be identified at diagnosis? A reassessment 2 years after initial diagnosis.

Authors:  A T Berg; S Shinnar; S R Levy; F M Testa; S Smith-Rapaport; B Beckerman
Journal:  Epilepsia       Date:  2000-10       Impact factor: 5.864

4.  Validation of the rat model of cryptogenic infantile spasms.

Authors:  Tamar Chachua; Mi-Sun Yum; Jana Velíšková; Libor Velíšek
Journal:  Epilepsia       Date:  2011-08-19       Impact factor: 5.864

Review 5.  How do the many etiologies of West syndrome lead to excitability and seizures? The corticotropin releasing hormone excess hypothesis.

Authors:  K L Brunson; M Eghbal-Ahmadi; T Z Baram
Journal:  Brain Dev       Date:  2001-11       Impact factor: 1.961

6.  Continuous electroencephalographic monitoring with radio-telemetry in a rat model of perinatal hypoxia-ischemia reveals progressive post-stroke epilepsy.

Authors:  Shilpa D Kadam; Andrew M White; Kevin J Staley; F Edward Dudek
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

7.  The effects of age on the kindling phenomenon.

Authors:  S L Moshé
Journal:  Dev Psychobiol       Date:  1981-01       Impact factor: 3.038

8.  Infantile spasms in Down syndrome--effects of delayed anticonvulsive treatment.

Authors:  Monika Maria Eisermann; A DeLaRaillère; G Dellatolas; E Tozzi; R Nabbout; O Dulac; C Chiron
Journal:  Epilepsy Res       Date:  2003 Jun-Jul       Impact factor: 3.045

9.  Bumetanide inhibits rapid kindling in neonatal rats.

Authors:  Andréy Mazarati; Don Shin; Raman Sankar
Journal:  Epilepsia       Date:  2009-02-26       Impact factor: 5.864

10.  Long-term otucome of West syndrome: a study of adults with a history of infantile spasms.

Authors:  R Riikonen
Journal:  Epilepsia       Date:  1996-04       Impact factor: 5.864

View more
  9 in total

1.  Animal models of neurological disorders.

Authors:  Marie-Francoise Chesselet; S Thomas Carmichael
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

2.  Comment on: "Clinical management of seizures in newborns: diagnosis and treatment".

Authors:  Eugenio Grillo
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

Review 3.  Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System.

Authors:  Nithya Srinivas; Kaitlyn Maffuid; Angela D M Kashuba
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

Review 4.  Issues related to development of antiepileptogenic therapies.

Authors:  Asla Pitkänen; Astrid Nehlig; Amy R Brooks-Kayal; F Edward Dudek; Daniel Friedman; Aristea S Galanopoulou; Frances E Jensen; Rafal M Kaminski; Jaideep Kapur; Henrik Klitgaard; Wolfgang Löscher; Istvan Mody; Dieter Schmidt
Journal:  Epilepsia       Date:  2013-08       Impact factor: 5.864

Review 5.  Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.

Authors:  Wolfgang Löscher
Journal:  Neurochem Res       Date:  2017-03-13       Impact factor: 3.996

6.  Gastrodin Suppresses Pentylenetetrazole-Induced Seizures Progression by Modulating Oxidative Stress in Zebrafish.

Authors:  Meng Jin; Qiuxia He; Shanshan Zhang; Yixuan Cui; Liwen Han; Kechun Liu
Journal:  Neurochem Res       Date:  2018-02-07       Impact factor: 3.996

Review 7.  Modulation of antioxidant enzymatic activities by certain antiepileptic drugs (valproic acid, oxcarbazepine, and topiramate): evidence in humans and experimental models.

Authors:  Noemí Cárdenas-Rodríguez; Elvia Coballase-Urrutia; Liliana Rivera-Espinosa; Arantxa Romero-Toledo; Aristides Sampieri; Daniel Ortega-Cuellar; Hortencia Montesinos-Correa; Esaú Floriano-Sánchez; Liliana Carmona-Aparicio
Journal:  Oxid Med Cell Longev       Date:  2013-12-17       Impact factor: 6.543

Review 8.  Modeling PCDH19-CE: From 2D Stem Cell Model to 3D Brain Organoids.

Authors:  Rossella Borghi; Valentina Magliocca; Marina Trivisano; Nicola Specchio; Marco Tartaglia; Enrico Bertini; Claudia Compagnucci
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

Review 9.  Novel Concepts for the Role of Chloride Cotransporters in Refractory Seizures.

Authors:  Pavel A Kipnis; Shilpa D Kadam
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.